Congestive Heart Failure (CHF)

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: April 11, 2026Bookmark

Congestive Heart Failure (CHF) is a disorder of the pumping or filling ability of the heart. The most common cause is coronary artery disease and chronic hypertension. It commonly presents with symptoms suggesting volume overload.

According to the American Heart Association (AHA), heart failure is defined as a constellation of signs and symptoms caused by structural or functional impairment of ventricular filling and/or ejection of blood, leading to the cardinal symptoms (dyspnea and fatigue), and signs (edema and rales) of heart failure.

Definition of terms

TermDefinition
Congestive Heart Failure (CHF)A clinical syndrome in which the heart is unable to pump enough blood to meet the metabolic needs of the body
Heart Failure with Reduced Ejection Fraction (HFrEF)Formerly systolic Heart failure. CHF with reduced stroke volume, reduced ejection fraction (Left Ventricular Ejection Fraction ≤ 35-40%)
Heart Failure with Preserved Ejection Fraction (HFpEF)Formerly, diastolic Heart failure. CHF with reduced stroke volume, normal or reduced end-diastolic volume, and preserved ejection fraction (Left Ventricular Ejection Fraction 50-70%)
Borderline HFpEFhas a Left Ventricular Ejection Fraction of 40-49%
Right Heart Failure (RHF)CHF due to right ventricular dysfunction resulting in congestion of blood in the vena cava and peripheral veins, which increases venous hydrostatic pressure and results in peripheral edema, increased jugular venous pressure, ascites, and hepatomegaly
Left Heart Failure (LHF)CHF due to ventricular dysfunction resulting in tissue hypoperfusion and increased pulmonary capillary pressure.
Biventricular or Global heart failureCHF in which both the left and right ventricles are affected, resulting in the development of both RHF and LHF symptoms
Chronic compensated heart failureCHF on echocardiography, but the patient is asymptomatic or symptomatic and stable
Acute decompensated heart failureSudden deterioration of CHF or new onset of CHF due to an acute cardiac condition such as myocardial infarction

Framingham’s diagnostic criteria for heart failure

CategoryCriteria
Major criteriaAcute pulmonary oedema, cardiomegaly, hepatojugular reflux, neck vein distension, PND or orthopnea, rales, third heart sound gallop
Minor criteriaAnkle edema, dyspnea on exertion, hepatomegaly, nocturnal cough, pleural effusion, tachycardia (>120)

NYHA Heart Failure Classification – based on the patient’s functional capacity. It has prognostic value.

NYHA ClassLimitation to physical activitySigns and symptoms
Class INo limitation of physical activityOrdinary physical activity does not cause symptoms
Class IISlight limitation of physical activityComfortable at rest. Ordinary physical activity causes symptoms
Class IIIMarked limitation of physical activityComfortable at rest. Less than ordinary activity causes symptoms
Class IVSevere limitation of physical activitySymptoms are present even at rest

HFrEF vs HFpEF

HFrEFHFpEF
PathophysiologyImpaired contractility; Dilated HeartImpaired relaxation and filling; Hypertrophic heart
Ejection fractionReducedNormal/Preserved
SymptomsSimilar presentationSimilar presentation
MurmurS3S4
PatientCoronary artery disease, Prior myocardial infarctionLong-standing hypertension, Varied history
InvestigationsCXR, EKG, EchoCXR, EKG, Echo
EchocardiographyEF <40%, CardiomegalyPreserved EF
ManagementRate control (BB); Afterload reduction (ACEi) +/- Diuretic. Treat the underlying causeControl hypertension; Judicious use of diuretics in exacerbation. Treat the underlying cause
  • Causes of heart failure
  • Pathophysiology
    • Underlying mechanisms
      • HFrEF: reduced contractility → ↓ LVEF → ↓ cardiac output
      • HFpEF: ↓ compliance → impaired filling + ↑ diastolic pressure → ↓ cardiac output (normal LVEF)
      • Left-sided HF: ↑ afterload (hypertension, aortic stenosis); ↑ preload (aortic regurgitation)
      • Right-sided HF: ↑ afterload (pulmonary hypertension); ↑ preload (tricuspid regurgitation, left-to-right shunts)
    • Compensatory mechanisms
      • Structural changes: hypertrophy and dilation (volume overload → chamber dilation; pressure overload → wall thickening)
      • Neurohumoral: RAAS (↑ TPR, ↑ fluid retention); sympathetic activation (↑ HR, ↑ contractility, ↑ venous return); ANP (↑ natriuresis)
      • Frank-Starling: ↑ preload → ↑ stretch → transient ↑ stroke volume
    • Effects of compensation
      • Adrenergic desensitization → ↓ catecholamine response
      • Myocyte loss → due to chronic stress
      • Worsened congestion → fluid overload
      • ↓ Cardiac output → due to ↑ afterload
      • Adverse remodeling → angiotensin II & aldosterone effects
  • Signs and symptoms
    • Shortness of Breath
    • Dyspnea
    • Easy fatiguability
    • Peripheral oedema
    • Orthopnea
  • Differentials
    • Deconditioning – the patient may be out of shape, which happens with age
    • Isolated valvular lesions
    • Primary lung disease, e.g., COPD
    • Renal disease, e.g., nephrotic syndrome

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team